ArticleExploratory research in clinical and social pharmacy2026
Implementation of a deprescribing guideline by community pharmacists: A focus group study.
Article in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polypharmacy is common in older adults and, independent of underlying multimorbidity, is associated with adverse drug events, reduced quality of life, and increased healthcare use. Deprescribing can help address these issues. Pharmacists can identify deprescribing opportunities during clinical medication reviews (CMRs), and guidelines may support this process. However, their impact depends on successful implementation. Objectives: To identify determinants relevant for the implementation of this deprescribing guideline based on CPs' experiences with its use in clinical practice. Methods: Online focus groups were held with community pharmacists from the intervention group of a cluster randomized trial evaluating guideline-assisted deprescribing during CMRs in older patients with hyperpolypharmacy (≥10 medications). Pharmacists received training on the guideline and its drug-specific fact sheets. The topic guide was informed by the Results: Nineteen of 24 eligible pharmacists participated in three focus groups. Across seven TICD domains, 26 determinants were identified. There were few barriers related to the guideline itself, with pharmacists appreciating the layered structure and summaries and applicability of recommended interventions. At personal level, their ability to identify deprescribing opportunities and to monitor clinical outcomes was considered relevant. . At patient level, barriers included limited knowledge and ambivalent attitudes. Key influences regarding professional interaction included general practitioners' familiarity with deprescribing, clarity of task allocation, and interprofessional trust. Regarding resources insufficient reimbursement, and lack of integrated decision support were reported as barriers. Conclusions: Drug-specific fact sheets support deprescribing but do not fully address the complexity of decision-making in practice. Implementation is influenced by clinical uncertainty, experience, interprofessional collaboration, and organisational factors. Strengthening decision support, collaboration, and organisational conditions is essential for sustainable implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.